Articles & Reports Archive - Page 28 of 332 - The Source on HealthCare Price and Competition

Health Insurance Loss during COVID-19 May Increase Support for Universal Health Coverage

February 1, 2022

The No Surprises Act: A Bipartisan Achievement to Protect Consumers from Unexpected Medical Bills

February 1, 2022

On the Misuse of Regressions of Price on the HHI in Merger Review

February 1, 2022

Paying patients to use lower-priced providers

February 1, 2022

Physician Compensation Arrangements and Financial Performance Incentives in US Health Systems

January 28, 2022

Simulating the Impact of the Drug Price Negotiation Proposal in the Build Back Better Act

January 27, 2022

Transparency and the Doctor–Patient Relationship — Rethinking Conflict-of-Interest Disclosures List of authors.

January 22, 2022

Surprise Medical Bills Are Ending, but Controversy Continues

January 20, 2022

The Prices That Commercial Health Insurers and Medicare Pay for Hospitals’ and Physicians’ Services

January 20, 2022

Prescription Drugs: Spending, Use, and Prices

January 19, 2022

State Trends in Employer Premiums and Deductibles, 2010–2020

January 12, 2022

Promoting Competition in Drug Pricing: A Review of Recent Congressional Legislation

January 10, 2022

Examining 2021’s brand drug price increases and sneaking a peak at the early price hikes of 2022

January 3, 2022

ACO Investment Model Produced Savings, But The Majority Of Participants Exited When Faced With Downside Risk

January 3, 2022

How Price Regulation Is Needed To Advance Market Competition

January 3, 2022

How Do Commercial Insurance Plans Fare Under Proposed Prescription Drug Price Regulation?

December 23, 2021